Biotech Stocks Mired in Uncertainty: China Deal, Drug Pricing Politics and Earnings Outlook…Update-2 Rally Day
rotahaler price transmit by | Oct 10, 2019 | Biopharmaceuticals
http://umta.co.uk/41030-nexium-best-price.html discuss Update-2 10/13...Biotech IPOs Remain Weak-Recent rally was weak for small cap biotechs Vir Biotechnology (VIR): A clinical stage immunology and infectious disease Company focused on new therapies...
read moreLarge Cap Biopharma in Focus: Core Positions…Risk OFF…Updates
buy terramycin by | Oct 7, 2019 | Biopharmaceuticals
lantus solostar price walmart 10/09/19 Better tape today but a lot of random churning and tactical trading, biopharma under siege? NASDAQ up 1.17%. Talk about mini-deal with China. Large cap leaders with IBB flat: REGN MRK BMY....
read moreBiotech Snapshot: Bears Are Digging In…Update-2… Upside Reversal
by | Oct 2, 2019 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
Update-2 10/4 Broad Rally day: all major averages up 1.4%, NAZ at 7982. Risk back on. But biotech lags major indices IBB up 0.75%, XBI up 0.21% to $76.82. Better trade for biotech has been large...
read moreBiopharma Stocks Mired in Macro-Risk Off…Update-2…”Future of Biotech” from Barrons’s
With biotech in a funk this timely article from Barron's should help. Barron's to the Rescue: Future of Biotech, article offers picks from a new Roundtable (above link may not open because requires...
read more
Reuters Healthcare
- Teva to donate over $15 billion worth of drugs in opioid settlement: source October 16, 2019
- Suicide attempts rising among black teens October 16, 2019
- Brexit healthcare fears fuel expatriate insurance interest in Europe October 16, 2019
- Bayer expects significant surge in number of U.S. glyphosate cases October 16, 2019